Reviva Pharmaceuticals Holdings, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
14.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.29
|
-0.18
|
0.11
|
37.93%
|
|
2022-06-30
|
-0.35
|
-0.29
|
0.06
|
17.14%
|
|
2022-03-31
|
-0.28
|
-0.40
|
-0.12
|
-42.86%
|
|
2021-12-31
|
-0.25
|
-0.22
|
0.03
|
12.00%
|
|
2021-09-30
|
-0.23
|
-0.12
|
0.11
|
47.83%
|
|
2021-06-30
|
-0.24
|
-0.12
|
0.12
|
50.00%
|
|
2021-03-31
|
-0.10
|
-0.10
|
0.00
|
0.00%
|
|
2020-12-31
|
-0.06
|
-0.16
|
-0.10
|
-166.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.87
|
|
2021-12-31
|
-0.56
|
|
2020-12-31
|
-0.31
|
|
2019-12-31
|
0.42
|
|
2018-12-31
|
0.14
|